Transient osteoporosis associated with pregnancy: use of bisphosphonate in treating a lactating mother
- PMID: 22802275
- PMCID: PMC3027861
- DOI: 10.1136/bcr.07.2009.2112
Transient osteoporosis associated with pregnancy: use of bisphosphonate in treating a lactating mother
Abstract
Transient osteoporosis is a rare condition causing regional pain, immobility and functional compromise. The authors present the case of a pregnant lady with multiple sites of transient osteoporosis, including a stress fracture, successfully treated with intravenous pamidronate and a physical rehabilitation programme. The authors discuss the mechanisms for the syndrome and its overlap with complex regional pain syndrome type I; as well as the implications of bisphosphonate administration to a nursing mother. The authors also highlight the advantages of MRI over standard radiography when investigating unexplained foot pain.
Conflict of interest statement
Figures





Similar articles
-
Intravenous bisphosphonate treatment and pregnancy: its effects on mother and infant bone health.Osteoporos Int. 2010 Nov;21(11):1959-62. doi: 10.1007/s00198-009-1138-0. Epub 2010 Jun 10. Osteoporos Int. 2010. PMID: 20535608
-
Clinical characteristics and bisphosphonates treatment of rare pregnancy- and lactation-associated osteoporosis.Clin Rheumatol. 2018 Nov;37(11):3141-3150. doi: 10.1007/s10067-018-4185-0. Epub 2018 Jun 26. Clin Rheumatol. 2018. PMID: 29946989
-
A case of regional migratory osteoporosis.Osteoporos Int. 2018 Feb;29(2):507-510. doi: 10.1007/s00198-017-4240-8. Epub 2017 Oct 24. Osteoporos Int. 2018. PMID: 29064043 Free PMC article.
-
Ibandronate, an experimental intravenous bisphosphonate for osteoporosis, bone metastases, and hypercalcemia of malignancy.Pharmacotherapy. 2006 May;26(5):655-73. doi: 10.1592/phco.26.5.655. Pharmacotherapy. 2006. PMID: 16637795 Review.
-
What is a 'failure' of bisphosphonate therapy for osteoporosis?Cleve Clin J Med. 2005 Nov;72(11):1033-9. doi: 10.3949/ccjm.72.11.1033. Cleve Clin J Med. 2005. PMID: 16315442 Review.
Cited by
-
Musculoskeletal problems in pregnancy.Rheumatol Int. 2015 Apr;35(4):581-7. doi: 10.1007/s00296-014-3135-7. Epub 2014 Sep 25. Rheumatol Int. 2015. PMID: 25253297 Review.
-
Transient Osteoporosis of the Hip in the Third Trimester: A Report of a Rare Case.Cureus. 2025 Feb 19;17(2):e79267. doi: 10.7759/cureus.79267. eCollection 2025 Feb. Cureus. 2025. PMID: 40125141 Free PMC article.
-
Transient osteoporosis in the third trimester of pregnancy: A case report.Case Rep Womens Health. 2022 Feb 14;34:e00400. doi: 10.1016/j.crwh.2022.e00400. eCollection 2022 Apr. Case Rep Womens Health. 2022. PMID: 35242599 Free PMC article.
-
Transient osteoporosis of the hip after bariatric surgery.Arthroplast Today. 2018 Dec 7;5(1):32-37. doi: 10.1016/j.artd.2018.10.010. eCollection 2019 Mar. Arthroplast Today. 2018. PMID: 31020018 Free PMC article.
References
-
- Curtiss PH, Jr, Kincaid WE. Transitory demineralization of the hip in pregnancy. A report of three cases. J Bone Joint Surg Am 1959;41-A:1327–33 - PubMed
-
- Arayssi TK, Tawbi HA, Usta IM, et al. Calcitonin in the treatment of transient osteoporosis of the hip. Semin Arthritis Rheum 2003;32:388–97 - PubMed
-
- Berger CE, Kröner AH, Minai-Pour MB, et al. Biochemical markers of bone metabolism in bone marrow edema syndrome of the hip. Bone 2003;33:346–51 - PubMed
-
- Siminoski K, Fitzgerald AA, Flesch G, et al. Intravenous pamidronate for treatment of reflex sympathetic dystrophy during breast feeding. J Bone Miner Res 2000;15:2052–5 - PubMed
-
- Carmona-Ortells L, Carvajal-Méndez I, García-Vadillo JA, et al. Transient osteoporosis of the hip: successful response to deflazacort. Clin Exp Rheumatol 1995;13:653–5 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical